Pattern of failure and timing of progression on CDK4/6 inhibitor as first line therapy for HR+HER2- metastatic breast cancer invading different organ

First Author / 第一作者

GAU RUOH-YUN

Institution / 單位

Division of Breast surgery, Department of Surgery, Linkou Chang Gung Memorial Hospital, Taoyuan, Taiwan

Audio / 音訊檔

Author Group / 作者群

Shin-Cheh Chen1, Hsiu-Pei Tsai1, Shih-che Shen1, Wen-Ling Kuo1, Hsu-Huan Chou1, Hui-yu Ho1, Chia-Hui Chu1, Wei-Shan Chung1, Yung-Chang Lin2, Meng-ting Peng2, Chan-Keng Yang2, Chi-Chang Yu1*

Author Group Institution/ 作者群單位

1Division of Breast surgery, Department of Surgery, Linkou Chang Gung Memorial Hospital, Taoyuan, Taiwan 2Division of Hematology and oncology, Department of Internal medicine, Chang Gung Memorial Hospital, Linkou, Taoyuan, Taiwan

Category / 主題分類

Clinical Research

Keyword / 關鍵字

failure, CDK4/6i, distant metastasis

Back to list